16.01.2025, 10:15 - 11:45
– 2.9.2.22
SFB-Seminar
From Model to Market: Enhancing Phase 3 Design with MID
Jane Knöchel (InSilicoTrials, Sweden)
Model Informed Drug Development (MIDD) has revolutionized the way pharmaceutical companies approach Phase 3 clinical trials. By integrating predictive modeling, MIDD enables more accurate and...
mehr erfahren